Arich Enterprise Co., Ltd. (TPEX:4173)
21.35
-0.05 (-0.23%)
Dec 11, 2025, 1:30 PM CST
Arich Enterprise Revenue
Arich Enterprise had revenue of 367.74M TWD in the quarter ending September 30, 2025, with 15.90% growth. This brings the company's revenue in the last twelve months to 1.48B, up 19.56% year-over-year. In the year 2024, Arich Enterprise had annual revenue of 1.30B with 13.83% growth.
Revenue (ttm)
1.48B
Revenue Growth
+19.56%
P/S Ratio
1.07
Revenue / Employee
7.48M
Employees
198
Market Cap
1.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.30B | 157.69M | 13.83% |
| Dec 31, 2023 | 1.14B | 122.06M | 11.99% |
| Dec 31, 2022 | 1.02B | 72.36M | 7.65% |
| Dec 31, 2021 | 945.66M | -305.73M | -24.43% |
| Dec 31, 2020 | 1.25B | 139.25M | 12.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Pegavision | 6.90B |
| Center Laboratories | 1.57B |
| EirGenix | 936.18M |
| Oneness Biotech | 117.33M |
| Lumosa Therapeutics | 42.59M |